Net Cash Provided by (Used in) Financing Activities in USD of Salarius Pharmaceuticals, Inc. from Q1 2014 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2014 to Q1 2025.
  • Salarius Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $546K.
  • Salarius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1.06M, a 84% decline from 2023.
  • Salarius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.64M, a 234% increase from 2022.
  • Salarius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.99M, a 93% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Salarius Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $546K +$718K Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 -$173K -$509K -151% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $337K +$337K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $0 -$28.2M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $28.2M +$18.6M +193% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $9.62M +$8.11M +538% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $1.51M +$1.45M +2646% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-15
Q1 2018 $54.9K +$54.9K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $0 -$7.59K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2016 $7.59K -$80.8M -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2015 $80.8M +$70.2M +660% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q2 2014 $39.5M Feb 26, 2014 Jun 30, 2014 10-Q 2015-11-04
Q1 2014 $10.6M Feb 26, 2014 Mar 31, 2014 10-Q 2015-05-06

Salarius Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.06M -$5.58M -84% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 $6.64M +$4.65M +234% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 $1.99M -$26.3M -93% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $28.3M +$10.6M +59.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $17.7M +$14.1M +394% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $3.58M +$2.14M +149% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 $1.44M +$1.43M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 $2.63K* -$19.5K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $22.1K -$80.8M -100% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
2015 $80.8M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.